title: Neuroleptic malignant syndrome: an experience of four cases.
abstract: We report four cases of neuroleptic malignant syndrome occurring after administration of a typical antipsychotic haloperidol and a newer atypical antipsychotic clozapine. The management of these patients is discussed.
authors.affiliation: Dept of Psychiatry, LTMMC and LTMG Hospital, Sion, Mumbai.
authors.forename: N D
authors.initials: ND
authors.lastname: Desai
authors.forename: V K
authors.initials: VK
authors.lastname: Mundra
authors.forename: Y S
authors.initials: YS
authors.lastname: Gore
authors.forename: P J
authors.initials: PJ
authors.lastname: Diwan
authors.forename: S S
authors.initials: SS
authors.lastname: Jaydeokar
authors.forename: V
authors.initials: V
authors.lastname: Jain
authors.forename: R
authors.initials: R
authors.lastname: Sutharsan
authors.forename: A
authors.initials: A
authors.lastname: Agarwal
authors.forename: N D
authors.initials: ND
authors.lastname: Moulick
authors.forename: S M
authors.initials: SM
authors.lastname: Manocha
mesh_terms: D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects; D003024:Clozapine / Q000009:adverse effects; D005260:Female; D006220:Haloperidol / Q000009:adverse effects; D006801:Humans; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis / Q000209:etiology / Q000628:therapy
chemical_list: D014150:Antipsychotic Agents; D003024:Clozapine; D006220:Haloperidol